| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OptimizeRx Corp | Chief Commercial Officer | Common Stock | 74.3K | $1.52M | $20.49 | Nov 1, 2025 | Direct |
| OptimizeRx Corp | Chief Commercial Officer | Stock Option | 35.2K | Aug 21, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OPRX | OptimizeRx Corp | Nov 1, 2025 | 1 | -$34.7K | 4 | Nov 3, 2025 | Chief Commercial Officer |
| OPRX | OptimizeRx Corp | Aug 21, 2025 | 2 | $0 | 4 | Aug 25, 2025 | Chief Commercial Officer |
| OPRX | OptimizeRx Corp | May 15, 2025 | 3 | $0 | 4 | May 19, 2025 | Chief Commercial Officer |
| OPRX | OptimizeRx Corp | Dec 23, 2024 | 2 | $0 | 4 | Dec 27, 2024 | Chief Commercial Officer |
| OPRX | OptimizeRx Corp | Nov 1, 2024 | 1 | -$8.72K | 4 | Nov 5, 2024 | Chief Commercial Officer |
| OPRX | OptimizeRx Corp | Nov 1, 2023 | 2 | $0 | 4 | Nov 3, 2023 | Chief Commercial Officer |
| OPRX | OptimizeRx Corp | Oct 24, 2023 | 0 | $0 | 3 | Oct 30, 2023 | Chief Commercial Officer |